Small molecule drug compounds combining photosensitizer structures, their preparation methods, and applications.
CN117466924BActive Publication Date: 2026-11-17HEBEI MEDICAL UNIVERSITY
-1 Cites 0 Cited by
Patent Information
- Application Number
- CN202310794045.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-06-30
- Publication Date
- 2026-11-17
- Estimated Expiration
- 2043-06-30
Abstract
This invention relates to a small molecule drug combined with a photosensitizer structure, its preparation method, and its application. By combining a histone deacetylase inhibitor, an epidermal growth factor receptor inhibitor, and a nonsteroidal anti-inflammatory drug with a fluoroboron dipyrrole photosensitizer, tumor-targeting small molecule drugs BD-AF and BD-VO with both photodynamic therapy and chemotherapy capabilities were obtained. Oxygen-sparing photosensitizers BD-ASP, BD-SUL, and BD-IND with mitochondrial inhibition and PDT capabilities were also obtained. The invention has been verified to solve the problems of weak targeting of enhanced photosensitizers to tumor cells and hypoxia within tumors, thereby improving the therapeutic effect of photodynamic therapy.
Need to check novelty before this filing date? Find Prior Art
